Evidence map›Paper›PMID 16878123›Full record

ArticleEMBO reports2006

The CRY box: a second APCcdh1-dependent degron in mammalian cdc20.

Alexandra Reis, Mark Levasseur, Heng-Yu Chang, David J Elliott, Keith T Jones

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Novel regulation on the mitotic checkpoint revealed by knocking outFrontiers in cell and developmental biology · 2023
    Article
  4. Article
  5. E3 Ubiquitin Ligase APC/CInternational journal of molecular sciences · 2020
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alexandra ReisInstitute for Cell and Molecular Biosciences, The Medical School, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne NE2 4HH, UK.
Mark Levasseur
Heng-Yu Chang
David J Elliott
Keith T Jones
Newcastle University · GBCentre for Life · GB

Funding

Wellcome TrustWellcome Trust 075744
6 · The paper itself

Abstract

Cdc20 and cdh1 are coactivators of the anaphase-promoting complex (APC). APC(cdc20) is necessary for the metaphase-anaphase transition and, at the end of mitosis, vertebrate cdc20 itself becomes a target for degradation through KEN-box-dependent APC(cdh1) activity. By studying the degradation of fluorescent protein chimaeras in mammalian oocytes and early embryos, we found that cdc20 was degraded through two independent degradation signals (degrons), the KEN box and a newly described CRY box. In both oocytes and G1-stage embryos, the rate of degradation through the CRY box was greater than through the KEN box, although both were mediated by APC(cdh1). Thus, mammalian oocytes and embryos have the capacity to recognize two degrons in cdc20.

Indexed as

Anaphase-Promoting Complex-CyclosomeAnimalsCdc20 ProteinsCell Cycle ProteinsEmbryo, MammalianFemaleG1 PhaseGreen Fluorescent ProteinsMeiotic Prophase IMiceOocytesProtein DenaturationProtein Sorting SignalsProtein Structure, TertiaryRecombinant Fusion ProteinsUbiquitin-Protein Ligase ComplexesAnaphase-Promoting Complex-CyclosomeCdc20 protein, mouseCdc20 ProteinsCell Cycle ProteinsGreen Fluorescent ProteinsProtein Sorting SignalsRecombinant Fusion ProteinsUbiquitin-Protein Ligase Complexes

Identifiers

PMID16878123
PMCPMC1618383
OpenAlexW2074169462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.